Sale!

MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the MT-TY gene associated with serious kidney and heart conditions. This advanced next-generation sequencing test helps detect genetic abnormalities that cause focal segmental glomerulosclerosis (FSGS), a progressive kidney disease, and dilated cardiomyopathy, a condition where the heart becomes enlarged and weakened. The test is particularly valuable for individuals with family history of these disorders, unexplained kidney failure, or cardiac abnormalities. Results provide crucial information for personalized treatment planning, family planning decisions, and early intervention strategies. The test costs $500 USD and includes genetic counseling to help interpret results and understand inheritance patterns.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy NGS Genetic DNA Test

Comprehensive Genetic Analysis for Kidney and Heart Health

The MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy NGS Genetic DNA Test represents a breakthrough in precision medicine for individuals at risk of inherited kidney and heart disorders. This sophisticated diagnostic tool utilizes next-generation sequencing technology to identify specific genetic mutations in the MT-TY gene that are directly linked to the development of focal segmental glomerulosclerosis (FSGS) and dilated cardiomyopathy (DCM).

What This Advanced Genetic Test Detects

This comprehensive NGS-based test specifically targets mutations in the MT-TY mitochondrial gene, which plays a critical role in cellular energy production and function. The test identifies:

  • Pathogenic variants in the MT-TY gene associated with FSGS
  • Genetic mutations linked to dilated cardiomyopathy development
  • Mitochondrial DNA abnormalities affecting kidney and heart function
  • Inheritance patterns for family risk assessment
  • Specific genetic markers that influence treatment response

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is recommended for individuals experiencing:

  • Unexplained proteinuria or nephrotic syndrome
  • Progressive kidney dysfunction without clear cause
  • Family history of focal segmental glomerulosclerosis
  • Dilated cardiomyopathy with unknown etiology
  • Heart enlargement and reduced ejection fraction
  • Multiple family members with kidney or heart conditions
  • Early-onset kidney or cardiac disorders
  • Symptoms affecting both renal and cardiac systems

Significant Benefits of MT-TY Genetic Testing

Transformative Health Insights

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Early Disease Detection: Identify genetic risks before symptoms become severe
  • Personalized Treatment Planning: Tailor medical interventions based on genetic profile
  • Family Risk Assessment: Understand inheritance patterns for relatives
  • Reproductive Planning: Make informed decisions about family planning
  • Proactive Health Management: Implement preventive measures and monitoring
  • Reduced Diagnostic Uncertainty: Provide clear answers for complex medical presentations

Understanding Your Test Results

Comprehensive Result Interpretation

Your genetic test results will be thoroughly explained during your genetic counseling session. Possible outcomes include:

  • Positive Result: Identification of pathogenic MT-TY mutations indicating increased risk for FSGS and/or DCM
  • Negative Result: No detected mutations in the analyzed MT-TY gene regions
  • Variant of Uncertain Significance: Genetic changes with unknown clinical impact requiring further evaluation
  • Carrier Status: Information about inheritance patterns and family risk

All results are accompanied by detailed explanations and recommendations for next steps, including appropriate specialists for follow-up care in hepatology, nephrology, and endocrinology.

Test Pricing and Details

Test Feature Details
Test Name MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have conveniently located branches across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Take Control of Your Genetic Health Today

Don’t wait to understand your genetic risk for serious kidney and heart conditions. Our expert team is ready to guide you through the testing process and provide comprehensive support. Schedule your genetic counseling session and testing appointment now to gain valuable insights into your health future.

Call or WhatsApp us today at +1(267) 388-9828 to book your MT-TY genetic test and take the first step toward personalized healthcare.